β2-adrenoceptor polymorphisms: Relation between in vitro and in vivo phenotypes

Life Sciences

Volumn 74, Issue 23, 2004, Pages 2803-2814

  Leineweber, Kirsten ^a   Brodde, Otto Erich ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

2 adrenoceptor; Genotype; Haplotype; Linkage disequilibrium; Phenotype; Single nucleotide polymorphism

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADENYLATE CYCLASE; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HISTAMINE; ISOPRENALINE; NORADRENALIN; PROPRANOLOL; SALMETEROL; TERBUTALINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BLOOD FLOW; CHROMOSOME 5Q; DESENSITIZATION; DOWN REGULATION; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE MUTATION; GENETIC TRANSFECTION; HISTAMINE RELEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MISSENSE MUTATION; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN VARIANT; RNA TRANSLATION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; UNTRANSLATED REGION; VASCULAR RESISTANCE; VASODILATATION; WILD TYPE; CELL CULTURE; GENETICS; HAPLOTYPE; REVIEW;

CELLS, CULTURED; DOWN-REGULATION; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 1642544641     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.025     Document Type: Short Survey

References (44)

1. Aziz I., Hall I.P., McFarlane L.C., Lipworth B.J. Beta 2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Journal of Allergy and Clinical Immunology. 101:1998;337-341.
2. Barbato E., Penicka M., Delrue L., Vanderheyden M., Wijns W., Heyndrickx G., Goethals M., De Bruyne B., Bartunek J. Genetic modulation of human cardiac performance by Ile-164 polymorphism of beta-2 adrenergic receptor. Circulation. 106:2002;327-328.
3. 2-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension. 37:2001;1303-1308.
4. Brodde O.-E., Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacological Review. 51:1999;651-689.
5. 2-adrenoceptors. Circulation. 103:2001;1048-1050.
6. 2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo. Pharmacogenetics. 13:2003;59-66.
7. 2- adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo. American Journal of Physiology: Heart Circulatory Physiology. 285:2003;H2034-H2038.
8. 2-adrenergic receptor down-regulation. Clinical & Pharmacological Therapeutics. 74:2003;255-263.
9. 2 adrenoceptor gene polymorphisms in castic fibrosis lung disease. Pharmacogenetics. 12:2002;347-353.
10. Chong L.K., Chowdry J., Ghahramani P., Peachell P.T. Influence of genetic polymorphisms in the [beta]2-adrenoceptor on desensitisation in human lung mast cells. Pharmacogenetics. 10:2000;153-162.
11. 2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension. 36:2000;371-375.
12. 2-adrenoceptor (ADRB2) haplotypes. American Journal of Respiratory and Clinical Care Medicine. 158:1998;1968-1973.
13. 2 adrenoceptor polymorphism is associated with elevated immunglobulin E levels in asthmatic families. Journal of Allergy and Clinical Immunology. 100:1997;261-265.
14. Dishy V., Sofowora G.G., Xie H.G., Kim R.B., Byrne D.W., Stein C.M., Wood A.J. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. New England Journal of Medicine. 345:2001;1030-1035.
15. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proceedings of the National Academy of Science of the United States of America. 97:2000;10483-10488.
16. Fenech A., Hall I.P. Pharmacogenetics of asthma. Britisch Journal of Clinical Pharmacology. 53:2001;3-15.
17. 2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. Journal of Physiology. 546.2:2003;583-589.
18. Gratze G., Fortin J., Labugger R., Binder A., Kotanko P., Timmermann B., Luft F.C., Hoehe M.R., Skrabal F. Beta-2 adrenergic receptor variants affect resting blood pessure and agonist-induced vasodilation in young adult Caucasians. Hypertension. 33:1999;1425-1430.
19. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. Journal of Biological Chemistry. 268:1993;23116-23121.
20. s. European Journal of Pharmacology. 421:2001;141-147.
21. 2- adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 33:1994;9414-9419.
22. 2-adrenergic receptor structure. Pulmonary Pharmacology. 8:1995;1-10.
23. 2-adrenergic receptor genotype on signal transduction in human airway muscle cells. American Journal of Respiratory and Cell Molecular Biology. 13:1995;25-33.
24. 2-agonist therapy in asthma. European Respiratory Journal. 100:1998;3184-3188.
25. Hoffstedt J., Iliadou A., Pedersen N.L., Schalling M., Arner P. The effect of the beta2 adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. British Journal of Pharmacology. 133:2001;708-712.
26. Hoit B.D., Suresh D.P., Craft L., Walsh R.A., Liggett S.B. Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. American Heart Journal. 139:2000;537-542.
27. Johnson J.A., Terra S.G. β-Adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharmaceutical Research. 19:2002;1779-1787.
28. Joos L., Sandford A.J. Genotype predictors of response to asthma medications. Current Opinion in Pulmonary Medicine. 8:2002;9-15.
29. 2-adrenoceptor on the effects of β-adrenoceptor agonists on human lung mast cells. International Immunopharmacology. 3:2003;91-95.
30. Large V., Hellström L., Reynisdottir S., Lönnqvist F., Eriksson P., Lannfelt L., Arner P. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered beta-2 adrenoceptor function. Journal of Clinical Investigation. 100:1997;3005-3013.
31. 2- adrenergic receptor polymorphisms. News in Physiological Science. 10:1995;265-273.
32. 2-adrenergic receptor and asthma. American Journal of Respiratory and Clinical Care Medicine. 156:1997;S156-S162.
33. 2-adrenergic receptor polymorphisms adversely affects the outcome of congestive heart failure. Journal of Clinical Investigation. 102:1998;1534-1539.
34. 2- adrenoceptors in asthmatic patients. Chest. 115:1999;324-328.
35. 2-Adrenoceptor promotor polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells. Thorax. 57:2002;61-66.
36. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. Journal of Clinical Investigation. 100:1997;3184-3188.
37. McGraw D.W., Forbes S.L., Kramer L.A., Liggett S.B. Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. Journal of Clinical Investigation. 102:1998;1927-1932.
38. McNamara D.M., MacGowan G.A., London B. Clinical importance of β-adrenoceptor polymorphisms in cardiovascular disease. American Journal of Pharmacogenomics. 2:2002;73-78.
39. 2-adrenergic receptor gene and desensitisation in human airway smooth muscle. American Journal of Respiratory and Clinical Care Medicine. 162:2000;2117-2124.
40. Parola A.L., Kobilka B.K. The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J. Biol. Chem. 269:1994;4497-4505.
41. 2- adrenergic receptor gene. British Journal of Pharmacology. 126:1999;841-844.
42. 2-adrenergic receptor determine exercise capacity in patients with heart failure. Circulation Research. 86:2000;834-840.
43. 2 Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. American Journal of Respiratory and Clinical Care Medicine. 158:1998;787-791.
44. 2- adrenergic receptor polymorphisms: No association with essential hypertension in black and white Americans. Clinical & Pharmacological Therapeutics. 67:2000;670-675.